BSE filing, NSE: DAULAT. Summary written from the filing by ALFA Finder's alert engine.
Daulat Securities Ltd: key numbers
- Share price
- ₹28.00
- Market cap
- ₹14.00 Cr
- Revenue (annual)
- ₹-1.43 Cr
- Net profit (annual)
- ₹-1.79 Cr
- P/E (TTM)
- -16.9×Sector 19.7×
- Promoter holding
- 56.98%+0.56% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Daulat Securities Ltd
All →Daulat Securities Other Announcement
The company filed its quarterly shareholding pattern under Regulation 31 for the period ended September 30, 2026.
Daulat Securities Management Change
Daulat Securities Limited appointed Mr. Ajit Kochar as Managing Director following the resignation of Mr. Jitendra Kochar. The Board also discussed property monetisation strategies for its immovable assets.
Daulat Securities Other Announcement
A connected person of Daulat Securities acquired 400 equity shares via market purchase.
Daulat Securities Other Announcement
Connected person Aditi Bhutoria acquired 4,000 equity shares of Daulat Securities Ltd for Rs.1,19,360 via market purchase.
- Value
- ₹0.01 Cr
Daulat Securities Board Meeting Date
Daulat Securities intimated that its Board meeting is scheduled for 1 October 2026. Items include noting the MD's resignation and considering immovable property monetisation.
Daulat Securities Other Announcement
Connected person Aditi Bhutoria acquired 844 equity shares of Daulat Securities Ltd for Rs. 0.002 Crore via market purchase.
- Value
- ₹0.00 Cr
Other management change announcements
All →Kirloskar Brothers Management Change
Kirloskar Brothers' Independent Directors Vivek Pendharkar and Rekha Sethi completed their 5-year terms on 28 Oct 2026. They ceased from the Board and all committees.
iStreet Network Management Change
iStreet Network Ltd announced the resignation of Non-Executive Non-Independent Director Mr. Yash Maheshwari effective 13 October 2026. No financial impact is indicated.
Transgene Biotek Management Change
Transgene Biotek's statutory auditors Eswara Rao & Co. resigned effective 28 October 2026 citing pre-occupation. The company will appoint new auditors per applicable regulations.
Mobavenue AI Tech Management Change
Mobavenue AI Tech appointed Vikram Sheth as Chief of Corporate Development and Investor Relations. He will lead fundraising, acquisitions and investor relations.
Hexaware Technologies Management Change
Hexaware appointed Arjun Shah and Gregory Zeluck as Non-Executive Directors from 28 October 2026. Directors Neeraj Bharadwaj and Julius Genachowski resigned, and Girish Pai's resignation is effective 13 November 2026.
GMR Airports Management Change
GMR Airports appointed Sanjeev Gupta as Executive Director (Deputy CEO) effective 29 October 2026. Non-Executive Director Alexis Riols resigned effective 28 October 2026.